Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chubb
Merck
Johnson and Johnson
Queensland Health
Federal Trade Commission
Teva
AstraZeneca
Fish and Richardson

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076178

« Back to Dashboard

NDA 076178 describes NIZATIDINE, which is a drug marketed by Ani Pharms Inc, Apotex Inc, Dr Reddys Labs Ltd, Glenmark Generics, Mylan Pharms Inc, Sandoz, Watson Labs, and Amneal Pharms, and is included in ten NDAs. It is available from sixteen suppliers. Additional details are available on the NIZATIDINE profile page.

The generic ingredient in NIZATIDINE is nizatidine. There are seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Summary for 076178
Tradename:NIZATIDINE
Applicant:Sandoz
Ingredient:nizatidine
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 076178
Medical Subject Heading (MeSH) Categories for 076178
Suppliers and Packaging for NDA: 076178
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIZATIDINE nizatidine CAPSULE;ORAL 076178 ANDA Eon Labs, Inc. 0185-0150 N 0185-0150-05
NIZATIDINE nizatidine CAPSULE;ORAL 076178 ANDA Eon Labs, Inc. 0185-0150 N 0185-0150-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Jul 5, 2002TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Jul 5, 2002TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Merck
Julphar
Johnson and Johnson
Express Scripts
Fish and Richardson
AstraZeneca
QuintilesIMS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.